Literature DB >> 31403161

Role of lysyl oxidase like 1 in regulation of postpartum connective tissue metabolism in the mouse vagina†.

Ali Borazjani1, Bruna M Couri1,2, Mei Kuang1, Brian M Balog1, Margot S Damaser1,3,2,4,5.   

Abstract

Pelvic organ prolapse (POP) in lysyl oxidase like-1 knockout (Loxl1 KO) mice occurs primarily in parous mice and is rare in nulliparous mice. We determined the effect of Loxl1 deficiency on postpartum regulation of connective tissue metabolism genes and degradative enzyme activity in the vagina at 20 days gestation or 4 h, 48 h, 7 days, 15 days, 25 days, 7 weeks, or 12 weeks postpartum. Nulliparous Loxl1 KO and wildtype (WT) mice aged 11, 18, or 23 weeks were controls. Gene expression and enzyme activity were assessed using real-time quantitative reverse transcription PCR and fluorescein conjugated gelatin zymography, respectively. Parity, but not aging, had a significant influence on gene expression both with time postpartum and between KO and WT mice. Mmp2, Timp1, Timp2, Timp3, Timp4, Col1a1, Col3a1, Acta2, and Bmp1 were differentially expressed between KO and WT mice. Correlational analysis of gene-gene pairs revealed 10 significant differences between parous KO and WT groups, 5 of which were due to lack of co-expression of Bmp1 in KO mice. The overall enzyme activity that could be attributed to MMPs was significantly higher in WT compared to KO mice both 25 days and 12 weeks postpartum, and MMP activity was significantly lower 15 days and 25 days postpartum compared to KO nulliparous controls, but not WT. These findings suggest that Loxl1 deficiency combined with parity has a significant impact on postpartum regulation of connective tissue metabolism, particularly as it relates to co-expression of Bmp1 and altered proteolytic activity.
© The Author(s) 2019. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  extracellular matrix; lysyl oxidase like 1; parity; pelvic organ prolapse; postpartum; vagina

Mesh:

Substances:

Year:  2019        PMID: 31403161      PMCID: PMC7245155          DOI: 10.1093/biolre/ioz148

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  56 in total

1.  Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis.

Authors:  H P Rodemann; G A Müller
Journal:  Am J Kidney Dis       Date:  1991-06       Impact factor: 8.860

Review 2.  Utility of correlation measures in analysis of gene expression.

Authors:  Anthony Almudevar; Lev B Klebanov; Xing Qiu; Peter Salzman; Andrei Y Yakovlev
Journal:  NeuroRx       Date:  2006-07

3.  Pelvic organ prolapse in fibulin-5 knockout mice: pregnancy-induced changes in elastic fiber homeostasis in mouse vagina.

Authors:  Peter G Drewes; Hiromi Yanagisawa; Barry Starcher; Ian Hornstra; Katalin Csiszar; Spyridon I Marinis; Patrick Keller; R Ann Word
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

4.  The impact of cesarean delivery on pelvic floor dysfunction in lysyl oxidase like-1 knockout mice.

Authors:  Arlan Marcus Gustilo-Ashby; Una Lee; Drina Vurbic; David Sypert; Mei Kuang; Firouz Daneshgari; Matthew D Barber; Margot S Damaser
Journal:  Female Pelvic Med Reconstr Surg       Date:  2010-01       Impact factor: 2.091

5.  Decreased expression of elastin, fibulin-5 and lysyl oxidase-like 1 in the uterosacral ligaments of postmenopausal women with pelvic organ prolapse.

Authors:  Bai-hui Zhao; Jian-hong Zhou
Journal:  J Obstet Gynaecol Res       Date:  2012-04-09       Impact factor: 1.730

6.  Alteration of vaginal elastin metabolism in women with pelvic organ prolapse.

Authors:  Wenjun Zong; Suzan E Stein; Barry Starcher; Leslie A Meyn; Pamela A Moalli
Journal:  Obstet Gynecol       Date:  2010-05       Impact factor: 7.661

7.  Changes in expression of fibulin-5 and lysyl oxidase-like 1 associated with pelvic organ prolapse.

Authors:  Hyun Joo Jung; Myung Jae Jeon; Ga Won Yim; Sei Kwang Kim; Jong Rak Choi; Sang Wook Bai
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-05-18       Impact factor: 2.435

8.  Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.

Authors:  Joanna Stanczyk; Caroline Ospelt; Emmanuel Karouzakis; Andrew Filer; Karim Raza; Christoph Kolling; Renate Gay; Christopher D Buckley; Paul P Tak; Steffen Gay; Diego Kyburz
Journal:  Arthritis Rheum       Date:  2011-02

9.  Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis.

Authors:  Frédéric Reynier; Fabien Petit; Malick Paye; Fanny Turrel-Davin; Pierre-Emmanuel Imbert; Arnaud Hot; Bruno Mougin; Pierre Miossec
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

10.  Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate.

Authors:  Harvey J Motulsky; Ronald E Brown
Journal:  BMC Bioinformatics       Date:  2006-03-09       Impact factor: 3.169

View more
  3 in total

Review 1.  Mouse Knockout Models for Pelvic Organ Prolapse: a Systematic Review.

Authors:  Kristina Allen-Brady; Maria A T Bortolini; Margot S Damaser
Journal:  Int Urogynecol J       Date:  2022-01-28       Impact factor: 1.932

2.  Structural, functional and molecular pathogenesis of pelvic organ prolapse in patient and Loxl1 deficient mice.

Authors:  Yu Li; Nanfang Nie; Lin Gong; Fangyuan Bao; Chengrui An; Hongxia Cai; Xudong Yao; Yanshan Liu; Chunbo Yang; Bingbing Wu; XiaoHui Zou
Journal:  Aging (Albany NY)       Date:  2021-12-19       Impact factor: 5.682

Review 3.  Advances in molecular mechanisms of pelvic organ prolapse (Review).

Authors:  Zhi-Min Deng; Fang-Fang Dai; Meng-Qin Yuan; Dong-Yong Yang; Ya-Jing Zheng; Yan-Xiang Cheng
Journal:  Exp Ther Med       Date:  2021-07-15       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.